Posts Tagged ‘financial relationships’

New poll shows 81% of consumers are concerned over Pharma’s financial relationships with their doctors

Wednesday, August 25th, 2010

FiercePharma
By Tracy Staton
August 25, 2010

Another poll is showing that Americans skip drug doses to save money. More than 27 percent of adults told Consumer Reports that they’d skimped on their prescription meds, by forgoing doses, splitting pills to stretch their supplies, postponing refills and more.

Another part of the poll reported that Americans don’t trust their doctors to think independently about prescription drugs, not when Big Pharma is involved. Almost 70 percent of consumers surveyed think drugmakers have too much influence on physicians, and 81 percent say they’re worried about pharma gifts to–and financial relationships with–their doctors.

Half of the 1,150 people polled said they think doctors pick up their prescription pads too quickly, preferring drugs to non-pharma treatments such as lifestyle changes. Almost half said doctors are unduly influenced by gifts from drugmakers. Some 41 percent think doctors tend to prescribe newer, pricier drugs rather than older, cheaper alternatives.

Read the entire article here:  http://www.fiercepharma.com/story/patients-worry-pharma-taints-doctors-decisions/2010-08-25

« Return to news items


Share

Heavy Doses—Drug Company J&J Pays Docs Millions for “speaking & consulting gigs”

Friday, July 9th, 2010

Portfolio.com
By Brett Chases
July 9, 2010

Speaking and consulting gigs for drug companies can be lucrative for doctors.

Birmingham, Alabama, psychiatrist James E. Parker was paid more than $21,000 in speaking fees between January and March by a Johnson & Johnson company that sells mental health drugs.

Patricia Quinn, a retired Washington, D.C., physician and expert on attention deficit hyperactivity disorder, received more than $26,00 in the same period for consulting and speaking fees paid by a J&J company that markets Concerta, a leading drug for the condition.

The payments are part of just-released disclosures by J&J, which is following Pfizer Inc. and GlaxoSmithKline Plc in making public the amounts of money it pays physicians for speaking, consulting and conducting clinical trials.

Unlike other drug companies, J&J didn’t aggregate the total payments but the Wall Street Journal tallied the sum to be around $2.85 million in payments in the first quarter. J&J has a large medical device division and it pledges to divulge doctor payments for that business by next year. In three years, drug and device companies will be required to report such payments to the government as part of the new health reform law.

The financial relationships between doctors and health products companies are being scrutinized more closely by critics, Congress and the Justice Department. Pfizer’s decision to reveal its payments wasn’t voluntary. It agreed to do so as part of a $2.3 billion fraud settlement with the government. The company was accused to pushing docs to prescribe medicines for unapproved uses.

Read entire article:  http://www.portfolio.com/views/blogs/heavy-doses/2010/07/09/johnson-and-johnson-pays-doctors-millions-in-first-quarter

« Return to news items


Share